Greystone Financial Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,453
| Closed | -$1.72M | – | 106 |
|
|
2025
Q1 | $1.72M | Sell |
3,453
-247
| -7% | -$123K | 0.31% | 53 |
|
|
2024
Q4 | $1.92M | Buy |
3,700
+473
| +15% | +$246K | 0.33% | 53 |
|
|
2024
Q3 | $2M | Buy |
3,227
+100
| +3% | +$61.9K | 0.36% | 50 |
|
|
2024
Q2 | $1.73M | Buy |
3,127
+617
| +25% | +$341K | 0.34% | 50 |
|
|
2024
Q1 | $1.46M | Buy |
2,510
+335
| +15% | +$195K | 0.29% | 51 |
|
|
2023
Q4 | $1.15M | Buy |
2,175
+703
| +48% | +$373K | 0.27% | 56 |
|
|
2023
Q3 | $745K | Buy |
1,472
+39
| +3% | +$19.7K | 0.19% | 64 |
|
|
2023
Q2 | $748K | Buy |
+1,433
| New | +$748K | 0.17% | 68 |
|
|
2021
Q1 | – | Sell |
-4,092
| Closed | -$2.03M | – | 119 |
|
|
2020
Q4 | $2.03M | Buy |
+4,092
| New | +$2.03M | 0.55% | 50 |
|